Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 198
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics
The Rush for Iboga Looks Different from Gabon
FDA Issues Final Psychedelics Guidance, Schedules September Hearing on the Future of Psychedelic Therapies
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Reclaiming Ownership of Your Body With Psychedelics
Tackling Trauma with Pharmahuasca and DMT
World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder...
PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy
Psychedelic Bulletin: Tracking LSD Patents; Psilocybin Effective for a Year in...
PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic...
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S....
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...
Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent
COMPASS Pathways plc to announce fourth quarter and full year 2021...
Load more